A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate

Mise à jour : Il y a 4 ans
Référence : NCT01554696

Femme et Homme

Extrait

The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis subjects who are methotrexate-inadequate responders (MTX-IR).


Critère d'inclusion

  • Arthritis (rheumatoid)


Liens